Turinabol 10mg
€ 39,00
10 mg · 100 tablets · Oral research compound — Turinabol 10 mg tablets offer a non-aromatising, high-anabolic oral steroid perfect for lean-mass studies and strength-gain research. Its 16-hour half-life supports reliable twice-daily dosing with low water retention and a clear anti-estrogen profile.
Brand: Magnus Pharmaceuticals
Content: 100 tablets × 10 mg
Total Compound: 1,000 mg per box
Price: €39
Manufactured in: Europe
Magnus Pharmaceuticals’ Turinabol (4-Chlorodehydromethyltestosterone) is a Dianabol-derived oral compound known for its high anabolic:low androgenic profile, minimal water retention, and non-aromatising structure. With a ~16-hour half-life and peak plasma levels ~1 hour post-ingestion, it supports twice-daily dosing in lean-mass research and strength-adaptation trials.
Turinabol’s 4-chloro guard reduces estrogenic activity while its 17α-alkylation ensures oral bioavailability—though it introduces hepatic stress in prolonged use. Long detection windows (≥ 2 weeks) and WADA S1 classification make it a reliable positive-control compound in anti-doping validation research.
✅ Key Research HighlightsPrecise strength-gain profile with limited virilisation risk
Non-aromatising: no estrogenic side effects or water retention
PK-backed dosing: t½ ≈ 16 h, 10 mg twice daily
Lean-mass enhancement: improves nitrogen retention & red-cell mass
ISO-validated detection via M3/M4 LC-MS/MS metabolites
🔬 Suggested Laboratory ApplicationsAndrogenic activity vs. aromatisation-free models
Muscle strength and body-recomposition studies
Doping-assay development (LC-MS/MS workflows)
HPTA suppression and recovery investigations
📊 Technical SpecificationsField | Data |
---|---|
Chemical Name | 4-Chlorodehydromethyltestosterone |
Chemical Formula | C20H27ClO2 |
Synonyms | Turinabol; CDMT; Oral-T; 4-chloro-17β-hydroxy-17α-methylandrosta-1,4-dien-3-one |
Molecular Weight | 334.9 g/mol |
CAS Number | 2446-23-3 |
Per Tablet | 10 mg (100 tablets per box) |
Bioavailability | ≈ 100% oral · Renal excretion ≈ 60% of dose |
Detection Window | ≥ 2 weeks (M3/M4 metabolites, LC-MS/MS) |
Shelf Life | 36 months · Store ≤ 25 °C |
Research Focus | Key Findings |
---|---|
Anabolic:Androgenic Index | ~53 anabolic, ~0–6 androgenic (between Dianabol & Oxandrolone) |
Half-life & Dosing | ~16 h · 10 mg BID dosing keeps plasma active |
Lean Mass & Strength Effects | Positive nitrogen balance, improved strength, low aromatisation |
Erythropoietic Action | ↑ Hemoglobin & RBCs in short cycles |
Water Retention | Minimal due to 4-chloro substitution |
Risk Area | Noted Effects |
---|---|
Hepatotoxicity | 17-α alkylation linked to cholestasis & liver enzyme elevation |
Lipid Disruption | ↓ HDL / ↑ LDL; cardiovascular strain rises with dose and duration |
CNS/Cardio Activity | ↑ BP, HR, aggression in rodent & athlete models |
Doping Violation | Detected via WADA S1 banned list & long-term M3/M4 metabolites |
FOR RESEARCH USE ONLY.
Not intended for human or veterinary administration. Purchase confirms qualified-researcher status and acceptance of all handling and liability protocols. Any exposure will trigger a positive anti-doping result.
Reviews
Clear filtersThere are no reviews yet.